Clinical Trial Update: Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever [Phase 2]

View source ↗

Summary

Phase 2 trial comparing pharmacokinetics, tolerability, and safety of favipiravir versus ribavirin for Lassa fever has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lassa Fever

Drugs mentioned

• Favipiravir (favipiravir)
• Ribavirin (ribavirin)

Snippet

Sponsor: Bernhard Nocht Institute for Tropical Medicine | Conditions: Lassa Fever | Phase 2 | Status: COMPLETED